ThuLEP (Thulium Laser Enucleation of the Prostate) offers significant advantages in the treatment of benign prostatic hyperplasia (BPH). This advanced technique promotes rapid patient recovery while minimizing risks such as bleeding, urinary incontinence, and sexual dysfunction. The shallow penetration depth of Thulium laser energy into tissues results in significantly less bleeding. This characteristic is particularly beneficial for high-risk patients who cannot discontinue anticoagulant medication. The laser's precision allows for easier shaping and cutting of prostatic tissue, reducing trauma to the sphincter muscles responsible for urinary continence. Consequently, the risk of postoperative urinary incontinence is markedly decreased. Furthermore, the limited heat diffusion of Thulium laser energy minimizes exposure to the delicate neural structures surrounding the prostate that are crucial for erectile function, thereby better preserving postoperative erection quality. The high cutting efficiency of the laser facilitates precise tissue removal while maintaining anatomical angles, which contributes to the preservation of ejaculation post-surgery. Beyond BPH treatment, Thulium laser technology also demonstrates superior outcomes in the endoscopic resection of bladder tumors, providing more accurate pathological results and staging compared to conventional electrocautery procedures.